Guillain-Barré syndrome in an immunocompromised patient and coccidioidomycosis infection

Hema R. Murali, Keith Anthony Josephs, E. F M Wijdicks

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A 70-year-old man was referred for evaluation of a 2-week history of numbness and progressive weakness in his lower and upper extremities and subsequently diagnosed with Guillain-Barré syndrome. The patient had been taking mycophenolate mofetil 500 mg twice daily and tacrolimus 6 mg daily for immunosuppression following a kidney transplant 2 years earlier. However, 5 weeks prior to presentation he had been diagnosed with pneumonia due to coccidioidomycosis and his tacrolimus dose was reduced to 1 mg daily to prevent a drug interaction with fluconazole, which was prescribed to treat the coccidioidomycosis infection. The authors surmise that the reduced tacrolimus dose, coupled with a relatively low maintenance dose of mycophenolate mofetil, left the patient less immunosuppressed and therefore able to mount an immune response to the coccidioidomycosis infection, resulting in Guillain-Barré syndrome. This is the first known report of an association between coccidioidomycosis infection and Guillain-Barré syndrome.

Original languageEnglish (US)
Pages (from-to)82-84
Number of pages3
JournalReviews in Neurological Diseases
Volume3
Issue number2
StatePublished - Mar 2006

Fingerprint

Coccidioidomycosis
Immunocompromised Host
Tacrolimus
Mycophenolic Acid
Infection
Hypesthesia
Fluconazole
Drug Interactions
Immunosuppression
Lower Extremity
Pneumonia
Transplants
Kidney

Keywords

  • Coccidioidomycosis
  • Guillain-Barré syndrome
  • Immunosuppression

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Guillain-Barré syndrome in an immunocompromised patient and coccidioidomycosis infection. / Murali, Hema R.; Josephs, Keith Anthony; Wijdicks, E. F M.

In: Reviews in Neurological Diseases, Vol. 3, No. 2, 03.2006, p. 82-84.

Research output: Contribution to journalArticle

@article{72dd012073ea487f87e077e3f0c9aff5,
title = "Guillain-Barr{\'e} syndrome in an immunocompromised patient and coccidioidomycosis infection",
abstract = "A 70-year-old man was referred for evaluation of a 2-week history of numbness and progressive weakness in his lower and upper extremities and subsequently diagnosed with Guillain-Barr{\'e} syndrome. The patient had been taking mycophenolate mofetil 500 mg twice daily and tacrolimus 6 mg daily for immunosuppression following a kidney transplant 2 years earlier. However, 5 weeks prior to presentation he had been diagnosed with pneumonia due to coccidioidomycosis and his tacrolimus dose was reduced to 1 mg daily to prevent a drug interaction with fluconazole, which was prescribed to treat the coccidioidomycosis infection. The authors surmise that the reduced tacrolimus dose, coupled with a relatively low maintenance dose of mycophenolate mofetil, left the patient less immunosuppressed and therefore able to mount an immune response to the coccidioidomycosis infection, resulting in Guillain-Barr{\'e} syndrome. This is the first known report of an association between coccidioidomycosis infection and Guillain-Barr{\'e} syndrome.",
keywords = "Coccidioidomycosis, Guillain-Barr{\'e} syndrome, Immunosuppression",
author = "Murali, {Hema R.} and Josephs, {Keith Anthony} and Wijdicks, {E. F M}",
year = "2006",
month = "3",
language = "English (US)",
volume = "3",
pages = "82--84",
journal = "Reviews in Neurological Diseases",
issn = "1545-2913",
publisher = "MedReviews LLC",
number = "2",

}

TY - JOUR

T1 - Guillain-Barré syndrome in an immunocompromised patient and coccidioidomycosis infection

AU - Murali, Hema R.

AU - Josephs, Keith Anthony

AU - Wijdicks, E. F M

PY - 2006/3

Y1 - 2006/3

N2 - A 70-year-old man was referred for evaluation of a 2-week history of numbness and progressive weakness in his lower and upper extremities and subsequently diagnosed with Guillain-Barré syndrome. The patient had been taking mycophenolate mofetil 500 mg twice daily and tacrolimus 6 mg daily for immunosuppression following a kidney transplant 2 years earlier. However, 5 weeks prior to presentation he had been diagnosed with pneumonia due to coccidioidomycosis and his tacrolimus dose was reduced to 1 mg daily to prevent a drug interaction with fluconazole, which was prescribed to treat the coccidioidomycosis infection. The authors surmise that the reduced tacrolimus dose, coupled with a relatively low maintenance dose of mycophenolate mofetil, left the patient less immunosuppressed and therefore able to mount an immune response to the coccidioidomycosis infection, resulting in Guillain-Barré syndrome. This is the first known report of an association between coccidioidomycosis infection and Guillain-Barré syndrome.

AB - A 70-year-old man was referred for evaluation of a 2-week history of numbness and progressive weakness in his lower and upper extremities and subsequently diagnosed with Guillain-Barré syndrome. The patient had been taking mycophenolate mofetil 500 mg twice daily and tacrolimus 6 mg daily for immunosuppression following a kidney transplant 2 years earlier. However, 5 weeks prior to presentation he had been diagnosed with pneumonia due to coccidioidomycosis and his tacrolimus dose was reduced to 1 mg daily to prevent a drug interaction with fluconazole, which was prescribed to treat the coccidioidomycosis infection. The authors surmise that the reduced tacrolimus dose, coupled with a relatively low maintenance dose of mycophenolate mofetil, left the patient less immunosuppressed and therefore able to mount an immune response to the coccidioidomycosis infection, resulting in Guillain-Barré syndrome. This is the first known report of an association between coccidioidomycosis infection and Guillain-Barré syndrome.

KW - Coccidioidomycosis

KW - Guillain-Barré syndrome

KW - Immunosuppression

UR - http://www.scopus.com/inward/record.url?scp=33745592189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745592189&partnerID=8YFLogxK

M3 - Article

C2 - 16819425

AN - SCOPUS:33745592189

VL - 3

SP - 82

EP - 84

JO - Reviews in Neurological Diseases

JF - Reviews in Neurological Diseases

SN - 1545-2913

IS - 2

ER -